Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 September 2021 | Story Leonie Bolleurs | Photo Supplied
Ofhani Mavhungu, Carina le Roux, Dr Foch de Witt , and Andries van der Merwe.

The Department of Animal Science at the University of the Free State (UFS) walked away with numerous awards at the 52nd congress of the South African Society for Animal Science (SASAS).

Dr Foch de Witt, Senior Lecturer in the department, explains that the SASAS congress is an annual event where scientists, academics, students, and various industry role players come together to share the latest research findings regarding different aspects of animal science and production. 

Acknowledging greatness

The SASAS Gold Medal was awarded to Prof Michiel Scholtz, affiliated professor in the department. “He was presented with this award for his honourable lifelong service to animal science. His scientific contributions and achievements have been recognised as exceptionally meritorious by both national and international animal scientists,” says Prof Frikkie Neser, Head of the Department of Animal Science.

Andries van der Merwe, a postgraduate student, received the SASAS Student Postgraduate Merit Award. According to Prof Neser, this is an annual national merit award to postgraduate students for exceptional academic achievement in Animal Science during undergraduate studies at any South African university.

Dr Sinobongo Mdyogolo, a PhD student of Prof Neser, was presented with the SASAS Bronze Medal in respect of her PhD achievements in the research and technology transfer categories. This is the highest honour a student can get after completion of their PhD degree.

During the SASAS congress, a total of 22 oral and poster contributions were delivered by staff and students from the Department of Animal Science.

A great networking opportunity 

Another highlight for the department was when three of its students – Carina le Roux, Ofhani Mavhungu, and Andries van der Merwe – participated in and won the SASAS national student quiz. Team UFS was one of 13 student teams from various tertiary institutions participating in the competition. The external panel of judges complemented the team on how they integrated theoretical principles in a practical and applied manner.

According to Dr De Witt, UFS Animal Science graduates compare very favourably with other students from tertiary institutions in South Africa. “Many of our students seek employment in the animal feed industry and they excel in their professional career development. It is clear that the curriculum updates of the past few years were successful in ensuring that students are able to integrate theoretical and practical concepts in an applied manner – a skill that is sought after in the industry,” he says. 

He also believes that an event such as the SASAS congress is an ideal network opportunity where students can get exposure to congress presentations, while having the opportunity to meet potential employers and/or sponsors.

“The SASAS congress creates a platform for students to measure themselves in terms of scientific development and career preparedness by interacting directly with other students from different tertiary institutions as well as industry members. Exposure to events such as this furthermore prepares them for their professional registration with the South African Council for Natural Scientific Professions (SACNASP),” adds Dr De Witt. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept